These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11403006)

  • 1. The global drug gap: policy implications for microbicides.
    Reich MR
    AIDS; 2001 Feb; 15 Suppl 1():S14-7. PubMed ID: 11403006
    [No Abstract]   [Full Text] [Related]  

  • 2. Eliminating neglected diseases: impact of published paper.
    Brownback S
    Health Aff (Millwood); 2007; 26(5):1509. PubMed ID: 17848471
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 4. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 5. Access denied to essential medicines in developing world.
    Ahmad K
    Lancet Infect Dis; 2002 Dec; 2(12):711. PubMed ID: 12467674
    [No Abstract]   [Full Text] [Related]  

  • 6. Innovation and the WHO's essential medicines list: giving credit where credit is due.
    Wertheimer AI; Santella TM
    Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
    [No Abstract]   [Full Text] [Related]  

  • 7. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 8. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

  • 9. The performance and problems of the Turkish pharmaceutical industry: is there a need to develop a national drug policy?
    Kisa A
    J Med Syst; 2001 Oct; 25(5):309-18. PubMed ID: 11508904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving access to medicines in poor countries: the role of universities.
    Chokshi DA
    PLoS Med; 2006 Apr; 3(6):e136. PubMed ID: 16608382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No deal in sight on cheap drugs for poor countries.
    Fleck F
    Bull World Health Organ; 2003; 81(4):307-8. PubMed ID: 12764500
    [No Abstract]   [Full Text] [Related]  

  • 12. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 13. Essential medicines twenty-five years on: closing the access gap.
    Quick JD
    Health Policy Plan; 2003 Mar; 18(1):1-3. PubMed ID: 12582103
    [No Abstract]   [Full Text] [Related]  

  • 14. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

  • 15. Access to medicines versus access to treatment: the case of type 1 diabetes.
    Beran D; McCabe A; Yudkin JS
    Bull World Health Organ; 2008 Aug; 86(8):648-9. PubMed ID: 18797626
    [No Abstract]   [Full Text] [Related]  

  • 16. A fair deal for the future: flexibilities under TRIPS.
    So AD
    Bull World Health Organ; 2004 Nov; 82(11):813. PubMed ID: 15640914
    [No Abstract]   [Full Text] [Related]  

  • 17. Patents and access to essential drugs.
    Loff B
    Trans R Soc Trop Med Hyg; 2003; 97(1):6-9. PubMed ID: 12886793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbicides 2000 conference. Welcoming remarks. Microbicides: global opportunities.
    Piot P
    AIDS; 2001 Feb; 15 Suppl 1():S4. PubMed ID: 11228108
    [No Abstract]   [Full Text] [Related]  

  • 19. The responsibility of research universities to promote access to essential medicines.
    't Hoen EF
    Yale J Health Policy Law Ethics; 2003; 3(2):293-300. PubMed ID: 14577145
    [No Abstract]   [Full Text] [Related]  

  • 20. Reprivatizing pharmaceutical supplies in Africa.
    Turshen M
    J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.